pleconaril has been researched along with Cross Infection in 1 studies
WIN 63843: structure given in first source
Cross Infection: Any infection which a patient contracts in a health-care institution.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Investigational agents such as the capsid inhibitors pleconaril and pocapavir show promise for treatment of neonatal enterovirus infections, and other investigational agents are being developed." | 4.98 | Neonatal nonpolio enterovirus and parechovirus infections. ( DeBiasi, RL; Harik, N, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harik, N | 1 |
| DeBiasi, RL | 1 |
1 review available for pleconaril and Cross Infection
| Article | Year |
|---|---|
Neonatal nonpolio enterovirus and parechovirus infections.
Topics: Antiviral Agents; Cross Infection; Enterovirus; Enterovirus Infections; Female; Fomites; Humans; Inf | 2018 |